NATCO Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	1,200	704	1,319	1,111	258
Short-Term Investments	-	23,699	13,208	6,612	6,488	7,919
Cash & Short-Term Investments	32,043	24,899	13,912	7,931	7,599	8,177
Cash Growth	30.08%	78.97%	75.41%	4.37%	-7.07%	-9.40%
Accounts Receivable	-	12,466	11,889	8,561	6,206	4,129
Other Receivables	-	1,045	706	351	545	721
Receivables	-	13,605	12,685	9,014	6,855	4,981
Inventory	-	8,494	7,917	8,089	8,620	9,104
Prepaid Expenses	-	305	289	283	326	226
Other Current Assets	-	5,397	5,432	4,686	1,467	960
Total Current Assets	-	52,700	40,235	30,003	24,867	23,448
Property, Plant & Equipment	-	26,573	24,350	23,034	23,084	22,372
Long-Term Investments	-	1,528	959	873	1,044	1,519
Goodwill	-	574	560	552	507	-
Other Intangible Assets	-	2,087	1,371	1,326	822	94
Long-Term Deferred Tax Assets	-	501	194	-	-	-
Other Long-Term Assets	-	2,345	1,394	786	767	472
Total Assets	-	86,308	69,063	56,574	51,091	47,919
Accounts Payable	-	2,749	2,355	2,638	1,618	1,462
Accrued Expenses	-	977	843	691	569	480
Short-Term Debt	-	2,731	3,781	1,744	4,205	2,821
Current Portion of Leases	-	17	27	6	35	9
Current Income Taxes Payable	-	790	323	101	9	13
Other Current Liabilities	-	2,171	2,399	1,651	668	471
Total Current Liabilities	-	9,435	9,728	6,831	7,104	5,256
Long-Term Leases	-	46	53	11	80	9
Pension & Post-Retirement Benefits	-	181	266	468	574	610
Long-Term Deferred Tax Liabilities	-	2	2	124	301	413
Other Long-Term Liabilities	-	521	483	402	396	397
Total Liabilities	-	10,185	10,532	7,836	8,455	6,685
Common Stock	-	358	358	365	365	365
Additional Paid-In Capital	-	12,019	12,019	14,065	14,078	13,915
Retained Earnings	-	63,061	45,252	33,518	27,261	26,277
Comprehensive Income & Other	-	632	902	790	932	659
Total Common Equity	86,498	76,070	58,531	48,738	42,636	41,216
Minority Interest	-	53	-	-	-	18
Shareholders' Equity	86,542	76,123	58,531	48,738	42,636	41,234
Total Liabilities & Equity	-	86,308	69,063	56,574	51,091	47,919
Total Debt	2,607	2,794	3,861	1,761	4,320	2,839
Net Cash (Debt)	29,436	22,105	10,051	6,170	3,279	5,338
Net Cash Growth	30.54%	119.93%	62.90%	88.17%	-38.57%	-6.86%
Net Cash Per Share	164.35	123.42	56.00	33.80	17.98	29.25
Filing Date Shares Outstanding	179.08	179.11	179.11	182.47	182.52	182.34
Total Common Shares Outstanding	179.08	179.11	179.11	182.47	182.52	182.34
Working Capital	-	43,265	30,507	23,172	17,763	18,192
Book Value Per Share	482.88	424.71	326.79	267.10	233.60	226.04
Tangible Book Value	83,896	73,409	56,600	46,860	41,307	41,122
Tangible Book Value Per Share	468.35	409.85	316.01	256.81	226.31	225.53
Land	-	5,265	3,692	2,855	2,641	2,476
Buildings	-	11,090	11,080	10,593	9,734	8,966
Machinery	-	19,485	18,340	17,616	16,798	15,013
Construction In Progress	-	2,254	1,373	643	1,295	2,234

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.